Similar articles

• Effects of antiallergic agents, compound 48/80, and some reference inhibitors on the activity of partially purified human lung tissue adenosine cyclic 3',5'-monophosphate and guanosine cyclic 3',5'-monophosphate phosphodiesterases.

  Bergstrand H, Kristoffersson J, Lundquist B, Schurmann A. Bergstrand H, et al. Mol Pharmacol. 1977 Jan;13(1):38-43. Mol Pharmacol. 1977. PMID: 189182 No abstract available.
• Effect of SCH 15280, a new bronchodilator, on cyclic 3',5'-nucleotide phosphodiesterase activity and cyclic 3',5'-adenosine monophosphate levels in guinea pig lung.

  Kreutner W, Sherwood JE. Kreutner W, et al. Biochem Pharmacol. 1977 May 15;26(10):951-4. doi: 10.1016/0006-2952(77)90473-7. Biochem Pharmacol. 1977. PMID: 193512 No abstract available.
• Inhibitory and activators of cyclic nucleotide phosphodiesterase.

  Chasin M, Harris DN. Chasin M, et al. Adv Cyclic Nucleotide Res. 1976;7:225-64. Adv Cyclic Nucleotide Res. 1976. PMID: 188316 Review. No abstract available.
• Comparison of in vivo and in vitro properties of cyclic adenosine 3':5'-monophosphate phosphodiesterase of amphibian oocytes.

  Allende CC, Bravo R, Allende JE. Allende CC, et al. J Biol Chem. 1977 Jul 10;252(13):4662-6. J Biol Chem. 1977. PMID: 194890 No abstract available.
• [Phosphodiesterase of cyclic nucleotides].

  Etingof RN, Dumler IL. Etingof RN, et al. Ukr Biokhim Zh (1978). 1981 Mar-Apr;53(2):28-43. Ukr Biokhim Zh (1978). 1981. PMID: 6266102 Review. Russian.